The comet assay www.selleckchem.com/products/Roscovitine.html revealed no significant Inhibitors,Modulators,Libraries differ ences in DNA damage between cells treated with only Doxorubicin and those treated with both Doxorubicin and Roscovitine six hours post drug removal. However, 24 hours after drug removal, while Doxorubicin only treated cells had completely repaired the damage, cells treated with both Doxorubicin and Roscovitine con tained a greater amount of DNA damage. These data further support the hypoth esis that Roscovitine Inhibitors,Modulators,Libraries can augment Doxorubicin induced DNA damage by hindering DSB repair over time. Combined treatment leads to global changes in DNA repair pathways To assess the global effects of combination treatment, we performed genome wide microarray analysis on cRNA from A549 cells treated for 24 hours with either 1 uM Doxorubicin alone or in combination with 20 uM Roscovitine.
Here we focus our analysis primarily on genes involved in the DNA repair pathways mismatch repair, nucleotide excision repair, homo logous recombination, and NHEJ. We grouped the genes related to these pathways that changed in a statis tically significant manner after combi nation treatment respect to Doxorubicin treatment in Table 1 and Figure 6. The most significant changes Inhibitors,Modulators,Libraries were observed in the NHEJ and HR pathways. In parti cular in HR we observed a decrease in BRCA1 and RAD50. Furthermore, there were significant variations in key genes involved in NHEJ. In particular, we observed a significant decrease in the expression levels of Ku80, DNA activated protein kinase, and NHEJ1. These data support the reduced NHEJ activity observed with the in vitro NHEJ plasmid re ligation assay.
Moreover, they demonstrate a more global affect on DNA repair pathways as a result of Inhibitors,Modulators,Libraries combination treatment with Roscovitine. Discussion Under genotoxic conditions the CDK2/cyclin A1 com plex increases its functional kinase activity and the abil ity to phosphorylate Ku70. In addition, here we demonstrated upon treatment with different DNA damaging agents Inhibitors,Modulators,Libraries a marked dose dependent increase in the RNA and protein levels of cyclin A1, which is independent of cell cycle phase redistribution. Conversely cyclin A2 is downregulated under genotoxic stress condi tions as a result of the check point activation and consequent decrease of the S phase fraction. This switch in the respective levels of the A family cyclins may be functionally relevant to redirect CDK2 activity toward DNA repair, especially given the findings that the ecto pic overexpression of cyclin Ixazomib Ki A1 increased in vitro NHEJ activity and that cyclin A1 depletion, as demonstrated by others, results in an impaired DNA DSB repair ability. DNA DSBs are considered the most lethal form of DNA damage and CDK inhibition has been shown to potentially affect the two major DSB repair pathways.